Literature DB >> 9391291

Time dependent alterations of serum matrix metalloproteinase-1 and metalloproteinase-1 tissue inhibitor after successful reperfusion of acute myocardial infarction.

S Hirohata1, S Kusachi, M Murakami, T Murakami, I Sano, T Watanabe, I Komatsubara, J Kondo, T Tsuji.   

Abstract

OBJECTIVE: To test the hypothesis that changes in serum matrix metalloproteinase-1 (MMP-1) and tissue inhibitors of metalloproteinase-1 (TIMP-1) after acute myocardial infarction reflect extracellular matrix remodelling and the infarct healing process. PATIENTS: 13 consecutive patients with their first acute myocardial infarction who underwent successful reperfusion.
METHODS: Blood was sampled on the day of admission, and on days 2, 3, 4, 5, 7, 14, and 28. Serum MMP-1 and TIMP-1 were measured by one step sandwich enzyme immunoassay. Left ventricular volume indices were determined by left ventriculography performed four weeks after the infarct.
RESULTS: Serum concentrations of both MMP-1 and TIMP-1 changed over time. The average serum MMP-1 was more than 1 SD below the mean control values during the initial four days, increased thereafter, reaching a peak concentration around day 14, and then returned to the middle control range. Negative correlations with left ventricular end systolic volume index and positive correlations with left ventricular ejection fraction were obtained for serum MMP-1 on day 5, when it began to rise, and for the magnitude of rise in MMP-1 on day 5 compared to admission. Serum TIMP-1 at admission was more than 1 SD below the mean control value, and increased gradually thereafter, reaching a peak on around day 14. Negative correlations with left ventricular end systolic volume index and positive correlations with left ventricular ejection fraction were obtained for serum TIMP-1 on days 5 and 7, and for the magnitude of rise in TIMP-1 on days 5 and 7 compared to admission.
CONCLUSIONS: Both MMP-1 and TIMP-1 showed significant time dependent alteration after acute myocardial infarction. Thus MMP-1 and TIMP-1 may provide useful information in evaluating the healing process as it affects left ventricular remodelling after acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9391291      PMCID: PMC484931          DOI: 10.1136/hrt.78.3.278

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  29 in total

1.  A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association.

Authors:  W G Austen; J E Edwards; R L Frye; G G Gensini; V L Gott; L S Griffith; D C McGoon; M L Murphy; B B Roe
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

2.  Left ventricular size after acute myocardial infarction. Serial changes and their prognostic significance.

Authors:  W J Kostuk; T M Kazamias; M P Gander; A L Simon; J Ross
Journal:  Circulation       Date:  1973-06       Impact factor: 29.690

3.  Estimation of left ventricular volume by one-plane cineangiography.

Authors:  D G Greene; R Carlisle; C Grant; I L Bunnell
Journal:  Circulation       Date:  1967-01       Impact factor: 29.690

4.  Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction.

Authors:  R M Norris; R M Whitlock; C Barratt-Boyes; C W Small
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

5.  A new approach for the enzymatic estimation of infarct size: serum peak creatine kinase and time to peak creatine kinase activity.

Authors:  M Horie; H Yasue; S Omote; A Takizawa; M Nagao; S Nishida; J Kubota
Journal:  Am J Cardiol       Date:  1986-01-01       Impact factor: 2.778

6.  The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism.

Authors:  A J Barrett; P M Starkey
Journal:  Biochem J       Date:  1973-08       Impact factor: 3.857

7.  Regulation of collagen degradation in the rat myocardium after infarction.

Authors:  J P Cleutjens; J C Kandala; E Guarda; R V Guntaka; K T Weber
Journal:  J Mol Cell Cardiol       Date:  1995-06       Impact factor: 5.000

8.  An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases.

Authors:  G Murphy; T E Cawston; J J Reynolds
Journal:  Biochem J       Date:  1981-04-01       Impact factor: 3.857

9.  Purification of rabbit bone inhibitor of collagenase.

Authors:  T E Cawston; W A Galloway; E Mercer; G Murphy; J J Reynolds
Journal:  Biochem J       Date:  1981-04-01       Impact factor: 3.857

10.  Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity.

Authors:  W E Shell; J K Kjekshus; B E Sobel
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

View more
  14 in total

Review 1.  Postinfarction left ventricular remodelling: where are the theories and trials leading us?

Authors:  Z R Yousef; S R Redwood; M S Marber
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

2.  Matrix metalloproteinases and cardiovascular diseases.

Authors:  A Papazafiropoulou; N Tentolouris
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

3.  Infarct size reduction and attenuation of global left ventricular remodeling with the CorCap cardiac support device following acute myocardial infarction in sheep.

Authors:  Aaron S Blom; James J Pilla; Robert C Gorman; Joseph H Gorman; Rupak Mukherjee; Francis G Spinale; Michael A Acker
Journal:  Heart Fail Rev       Date:  2005-06       Impact factor: 4.214

Review 4.  Myocardial remodeling: cellular and extracellular events and targets.

Authors:  Jennifer A Dixon; Francis G Spinale
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

5.  Plasma matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs and aging and lifelong exercise adaptations in ventricular and arterial stiffness.

Authors:  Graeme Carrick-Ranson; Francis G Spinale; Paul S Bhella; Satyam Sarma; Shigeki Shibata; Naoki Fujimoto; Jeffrey L Hastings; Benjamin D Levine
Journal:  Exp Gerontol       Date:  2019-05-13       Impact factor: 4.032

Review 6.  Molecular changes occurring during reverse remodelling following left ventricular assist device support.

Authors:  Emma J Birks; Robert S George
Journal:  J Cardiovasc Transl Res       Date:  2010-09-04       Impact factor: 4.132

Review 7.  MMP induction and inhibition in myocardial infarction.

Authors:  Merry L Lindsey
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

8.  Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction.

Authors:  Dominic Kelly; Sohail Q Khan; Matt Thompson; Gillian Cockerill; Leong L Ng; Nilesh Samani; Iain B Squire
Journal:  Eur Heart J       Date:  2008-07-08       Impact factor: 29.983

Review 9.  Matrix metalloproteinases and myocardial infarction.

Authors:  Wannakorn Phatharajaree; Arintaya Phrommintikul; Nipon Chattipakorn
Journal:  Can J Cardiol       Date:  2007-07       Impact factor: 5.223

10.  Matrix metalloproteinase-1 and tissue inhibitors do not predict incident coronary artery disease in the atherosclerosis risk in communities (ARIC) study.

Authors:  Vijay Nambi; Alanna C Morrison; Ron C Hoogeveen; Josef Coresh; Shawn Miles; Charles Etta Rhodes; A Richey Sharrett; B Eric Boerwinkle; Christie M Ballantyne
Journal:  Tex Heart Inst J       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.